GHK‑cu is a naturally occurring tripeptide present in the plasma of young people, which tends to decrease with age. It acts as a unique mediator: it transports copper ion, activates fibroblasts and stimulates angiogenesis. In practice, ghk‑cu restores skin density and elasticity, strengthens the barrier, intensively heals wounds and scars, and activates hair growth — improves thickness and nourishes hair follicles.
The peptide inhibits inflammation, acts as a powerful antioxidant, and regulates the expression of over 4,000 genes associated with cellular rejuvenation.
Raw MaterialUSA
Country of OriginUAE
Purity99%
Raw MaterialUSA
Purity99%
Country of OriginUAE
Indications
caring for mature, dehydrated and photo-damaged skin
post-procedural recovery (peels, lasers, surgery)
reduction of scars, accelerated healing of wounds and burns
stimulation of hair growth, strengthening of bulbs
fight against inflammation, dermatoses, post-acne
Contraindications
hypersensitivity or allergy to the components
pregnancy and lactation
GHK-Cu in ampoule format delivers a highly concentrated version of the copper tripeptide, targeting rapid and intensive skin regeneration. This form provides an immediate boost to fibroblast activity, enhances microcirculation, ac...
GHK-Cu in ampoule format delivers a highly concentrated version of the copper tripeptide, targeting rapid and intensive skin regeneration. This form provides an immediate boost to fibroblast activity, enhances microcirculation, accelerates healing, and increases the skin’s resilience to damage.
Ampoules are typically used during the initial phase of a protocol when a strong regenerative impulse is needed-whether to improve tissue density, brighten a dull complexion, correct post-procedure changes, or prepare the skin for aesthetic interventions.
GHK-Cu Ampoule is ideal for patients requiring accelerated regeneration, structural repair, and a pronounced remodeling effect. This format provides a fast visible improvement, strengthens dermal architecture, and boosts the efficacy of other peptide-based and device-based treatments.